INS and fatty liver disease: Following reduction in the amount of insulin the metabolism of acids in the liver is disrupted and eventually fatty liver is resulted which is followed by increases in ALT, AST, and ALP levels (Bush 1991 ▶; Jelodar, Nazifi, 1997 ▶).